STOCK TITAN

Vaxart, Inc. (VXRT) grants director 8,315 shares and 16,610 options

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Vaxart, Inc. director James B. Breitmeyer reported equity awards dated July 16, 2026. He acquired 8,315 shares of common stock in connection with restricted stock units that will vest on the earlier of the date immediately prior to the 2027 annual stockholder meeting and July 16, 2027, bringing his direct holdings to 87,115 shares. He was also granted options on 16,610 shares at an exercise price of $0.5149 per share, expiring July 16, 2036, with the options subject to the same vesting schedule.

Positive

  • None.

Negative

  • None.
Insider BREITMEYER JAMES B
Role Director
Type Security Shares Price Value
Grant/Award Stock Options (right to buy) 16,610 $0.00 --
Grant/Award Common Stock 8,315 $0.00 --
Holdings After Transaction: Stock Options (right to buy) — 16,610 shares (Direct); Common Stock — 87,115 shares (Direct)
Footnotes (1)
  1. Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary date of the grant. The shares subject to this option shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary of the date of the grant.
Common stock award 8,315 shares Shares acquired in connection with restricted stock units on July 16, 2026
Common shares held after grant 87,115 shares Direct Vaxart common stock holdings after the stock award
Option grant size 16,610 options Stock options (right to buy) granted on July 16, 2026
Option exercise price $0.5149 per share Conversion or exercise price for the 16,610 stock options
Option expiration July 16, 2036 Expiration date of the reported stock options
Vesting latest date July 16, 2027 Latest vesting date for both stock and option awards
restricted stock units financial
"Grant of shares upon vesting of restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
stock options (right to buy) financial
"Stock Options (right to buy) with an exercise price of 0.5149."
exercise price financial
"conversion_or_exercise_price: "0.5149" per share for the options."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The shares underlying the award shall vest on the earlier of the date immediately prior to the 2027 annual meeting."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What equity awards did Vaxart (VXRT) director James B. Breitmeyer receive?

James B. Breitmeyer received 8,315 shares of common stock and 16,610 stock options. The stock grant is linked to restricted stock units, and the options are exercisable for common shares at a specified exercise price and term.

What is the exercise price and term of the new Vaxart (VXRT) stock options?

The options give the right to buy 16,610 shares of Vaxart common stock at an exercise price of $0.5149 per share. These options expire on July 16, 2036, providing a long-dated incentive grant to the director.

How many Vaxart (VXRT) shares does James B. Breitmeyer hold after these transactions?

After the reported grant, James B. Breitmeyer directly holds 87,115 shares of Vaxart common stock. This total reflects the addition of 8,315 shares associated with restricted stock units subject to a future vesting schedule.

What is the vesting schedule for James B. Breitmeyer’s Vaxart (VXRT) restricted stock and options?

Both the 8,315-share stock award and the 16,610-share option grant vest on the earlier of the date immediately prior to Vaxart’s 2027 annual stockholder meeting and July 16, 2027, effectively tying vesting to either time or that meeting.

Are James B. Breitmeyer’s new Vaxart (VXRT) holdings reported as direct or indirect ownership?

The filing reports both the 8,315 shares of common stock and the 16,610 stock options as direct holdings. No indirect ownership entities or special ownership arrangements are referenced for these specific awards.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BREITMEYER JAMES B

(Last)(First)(Middle)
C/O VAXART, INC.
310 UTAH AVENUE, SUITE 150

(Street)
SOUTH SAN FRANCISCO CALIFORNIA 94080

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Vaxart, Inc. [ VXRT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/16/2026A8,315(1)A$087,115D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (right to buy)$0.514907/16/2026A16,610 (2)07/16/2036Common Stock16,610$016,610D
Explanation of Responses:
1. Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary date of the grant.
2. The shares subject to this option shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary of the date of the grant.
/s/ Edward Berg, Attorney-in-Fact07/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)